Webmaster - Mahidol University

BC Faculty Seminar: November 3, 2021

BC Faculty Seminar “Anti-cancer activity of asiatic acid against nasopharyngeal carcinoma cells” by Dr. Waraporn Komyod Department of Biochemistry, Faculty of Science, Mahidol University Join

Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma

Cholangiocarcinoma (CCA) is a cancer of the bile duct with no effective therapy. This study explores the potential of inducing ‘apoptosis’ and

RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach

Cholangiocarcinoma (CCA) originates from the biliary tract. CCA is associated with a high mortality rate and a concerning increase in incidence. Tumour

Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy

The study of immune evasion has gained a well-deserved eminence in cancer research due to the development of immune checkpoint inhibitors, such

Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma

Cholangiocarcinoma (CCA) originates from the biliary tract. CCA is associated with a high mortality rate and a concerning increase in incidence. Here we

Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis

Cholangiocarcinoma (CCA) is a lethal cancer of the bile duct and currently there is no effective therapy for this disease. This study

BC Faculty Seminar: October 6, 2021

BC Faculty Seminar “Therapeutic Potential of Ceritinib in Cholangiocarcinoma” by Prof. Rutaiwan Tohtong Department of Biochemistry, Faculty of Science, Mahidol University Join WebEx Meeting https://mahidol.webex.com/mahidol/j.php?MTID=m1c1dfe36aa68e5f8df5c9736d4f2d721

Author: Webmaster